roxithromycin

DRUG3 trials

Sponsors

Universitair Medisch Centrum Utrecht, Hamamatsu University, Nazilli State Hospital

Conditions

AlopeciaRespiratory tract infectionRheumatoid Arthritis

Phase 3

Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia

Active, not recruitingCTIS2023-507889-89-00

Universitair Medisch Centrum UtrechtRespiratory tract infection

Start: 2016-02-19Target: 3471Updated: 2025-11-14

Phase 4

Treatment of Rheumatoid Arthritis With Roxithromycin

CompletedNCT00439062

Nazilli State HospitalRheumatoid Arthritis

Start: 2006-06-30End: 2006-06-30Target: 100Updated: 2007-02-22

Unknown Phase

The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

Hamamatsu UniversityAlopecia

Start: 2005-05-31End: 2007-01-31Target: 20Updated: 2010-07-29